Repare Therapeutics
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $250 | $0 | $-53,477 | $53,477 |
Gross Profit | 250 | -1,186 | -454 | 40,099 |
EBITDA | -19,026 | -31,187 | -28,077 | -34,367 |
EBIT | -20,062 | -32,373 | -28,531 | -34,845 |
Net Income | -16,744 | -30,043 | -28,671 | -34,406 |
Net Change In Cash | 250 | 0 | -53,477 | 53,477 |
Free Cash Flow | -16,342 | -29,133 | -27,324 | -30,539 |
Cash | 67,656 | 84,455 | 84,717 | 80,541 |
Basic Shares | 42,921 | 42,591 | 42,411 | 42,452 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $53,477 | $51,133 | $131,830 | $7,600 |
Gross Profit | 40,099 | 37,894 | 15,108 | -80,254 |
EBITDA | -90,223 | -114,273 | -17,818 | -107,189 |
EBIT | -92,144 | -116,224 | -19,796 | -108,660 |
Net Income | -84,689 | -93,796 | -29,047 | -106,908 |
Net Change In Cash | 53,477 | 51,133 | 131,830 | 7,600 |
Cost of Revenue | 8,085 | |||
Free Cash Flow | -76,445 | -129,096 | -280 | -87,486 |
Cash | 84,717 | 111,268 | 159,521 | 334,427 |
Basic Shares | 42,411 | 42,093 | 41,922 | 37,818 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.39 |
2025-03-31 | -$0.71 |
2024-12-31 | -$0.67 |
